Global Pharmaceutical Blister Packaging Market, By Product Type (Clamshell, Carded), Technology Type (Cold Forming, Thermoforming), Material (Polyethylene Terephthalate (PET, PETE, PETG or Polyester), High Density Polyethylene (HDPE), Polyvinyl Chloride (PVC), Low Density Polyethylene (LDPE), Aluminum, Paper and Paper Board), Application (Tablets, Capsules, Powders, Medical Devices) – Industry Trends and Forecast to 2029.
Market Analysis and Size
Over the last decade, the global market landscape has changed dramatically and this period have been critical for the pharmaceutical industry. Until the mid-1990s, the United States, Europe, and Japan supplied 90% of the world's APIs (Active Pharmaceutical Ingredients). However, in the last ten years, changing market clusters, trade issues, and shifting manufacturing bases have shifted the focus to the Asia Pacific region. According to a recent study, China manufactures more than 40% of all APIs worldwide; however, India and China are the primary sources, accounting for more than 75% of API imports into the United States.
- Global pharmaceutical blister packaging Market was valued at USD 6.55 billion in 2021 and is expected to reach USD 10.39 billion by 2029, registering a CAGR of 5.60% during the forecast period of 2022-2029. "Polyvinyl chloride (PVC) " accounts for the largest material segment in the pharmaceutical blister packaging market owing to its lightweight, low cost, excellent barrier properties and inert nature.
Market Definition
A pharmaceutical product's packaging is an essential component. Packaging is frequently used in the dispensing, dosing, and administration of pharmaceutical products. Blister packaging is the most durable packaging type in the pharmaceutical industry, as it protects various pharmaceutical products from factors such as air, humidity, and moisture, which can cause contamination if they come into contact with them. It is highly popular because it protects medications, improves dosage compliance, and is easy to customize to fit the product design.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
USD 10.39 billion by 2029, registering a CAGR of 5.60%
|
|
Segments Covered
|
By Product Type (Clamshell, Carded), Technology Type (Cold Forming, Thermoforming), Material (Polyethylene Terephthalate (PET, PETE, PETG or Polyester), High Density Polyethylene (HDPE), Polyvinyl Chloride (PVC), Low Density Polyethylene (LDPE), Aluminum, Paper and Paper Board), Application (Tablets, Capsules, Powders, Medical Devices)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Schott (Germany), Amcor plc (Switzerland), Dow (U.S), AptarGroup, Inc., (US), Klöckner Pentaplast (Germany), West Pharmaceutical Services, Inc. (US), Berry Global Inc. (US), Honeywell International, Inc. (U.S), ACG (India), Nipro (Japan), Gerresheimer AG (Germany), Catalent Inc., (US), and WestRock Company (US)
|
Pharmaceutical Blister Packaging Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
-
Growing Awareness Associated with Blister Packaging
The blister packaging basically protects medication, improves dosage compliance, and can be easily customized to fit as per the product design, which is projected to accelerate the market's growth. The packaging protects various pharmaceutical products from factors including air, humidity, and moisture as contact of the products with these factors can lead to contamination, further boosting demand for the market.
-
Development and Advancements
Furthermore, increase in product innovations, growing use of the smart packaging for patient engagement and identification and merger and acquisition to support new demands are other market growth determinants. Advanced manufacturing processes to develop sustainable and eco-friendly packaging solutions also extend profitable opportunities to the market players in the forecast period of 2022 to 2029.
The rising geriatric population and increasing incident of chronic conditions, pushing the demand for new and effective pharmaceutical products carve the way for market's expansion. Additionally, increase in patient-oriented medicines, including biologics will bolster the growth of the market. Surging urbanization, higher economic growth and improvements in the quality of life, will further expand the future growth of the pharmaceutical blister packaging market.
Restraints/Challenges
-
Price Volatility to Restrict Growth of Market
The price volatility of raw materials will create hindrances for the growth of the pharmaceutical blister packaging market.
-
Stringent Government Regulations
The stringent government regulations and standard also challenge the pharmaceutical blister packaging market. Furthermore, the pandemic crisis results in lack of workforce, transportation restrictions, and shortage in raw materials and implementation of lockdown across the globe, which hampered the growth of market.
The lack of access and awareness in the emerging market is projected to hurdle the market's growth.
This pharmaceutical blister packaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical blister packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post COVID-19 Impact on Pharmaceutical Blister Packaging Market
The recent outbreak of coronavirus has critically impacted the various sectors across the globe. The materials and packaging sector was also grievously hit by the pandemic. The various lockdown and social distancing restrictions led to the large-scale disruptions in the supply chain, shortage of workers, transportation restrictions and raw material shortages resulting in downfall in the demand for pharmaceutical blister packaging.
However, the vaccines require different administration routes (e.g., inhaled, oral, transdermal, and injectable), demand for primary packaging can be extended across multiple packaging formats after vaccine approval. As a result, COVID-19 is expected to drive pharmaceutical packaging growth over the forecast period.
Recent Development
- In April 2020, Schott AG a German pharmaceutical glass manufacturer, introduced smart containers, which are laser-marked with a unique identifier to create robust traceability throughout the manufacturing process. The company has entered the digitised pharma manufacturing space. Every Smart Container is marked with a laser and a unique identifier, allowing for unprecedented traceability throughout the manufacturing process. The new concept allows pharma manufacturers to harness the power of machine vision and big data analytics on pharmaceutical filling lines. According to the German company, the new technology can be used to improve reject management and line clearance. It also lowers the chance of a mix-up, improves lyophilization processes, and facilitates container-based targeted recalls.
Global Pharmaceutical Blister Packaging Market Scope
The pharmaceutical blister packaging market is segmented on the basis of product type, technology type, material and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Clamshell
- Carded
On the basis of product type, the pharmaceutical blister packaging market has been segmented into clamshell and carded.
Technology Type
- Cold Forming
- Thermoforming
On the basis of technology type, the pharmaceutical blister packaging market has been segmented into cold forming and thermoforming.
Material
- Polyethylene Terephthalate,
- High Density Polyethylene (HDPE)
- Polyvinyl Chloride (PVC)
- Low Density Polyethylene (LDPE)
- Aluminum
- Paper and Paper Board
The pharmaceutical blister packaging market has also been segmented on the basis of material into polyethylene terephthalate, high density polyethylene (HDPE), polyvinyl chloride (PVC), low density polyethylene (LDPE), aluminum, paper and paper board. Polyethylene terephthalate includes PET, PETE, PETG or Polyester. Polyvinyl chloride (PVC) is the highest growing segment as compared to other materials as it the most popular raw material and is used owing to its light weight, low cost, excellent barrier properties and inert nature.
Application
- Tablets
- Capsules
- Powders
- Medical Devices
On the basis of application, the pharmaceutical blister packaging market is segmented into tablets, capsules, powders and medical devices.
Pharmaceutical Blister Packaging Market Regional Analysis/Insights
The pharmaceutical blister packaging market is analyzed and market size insights and trends are provided by country, product type, technology type, material and application as referenced above.
The countries covered in the pharmaceutical blister packaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the pharmaceutical blister packaging market because of the presence of major pharmaceutical companies, availability of advanced technological research platforms and the increasing funding towards research and development.
On the other hand, Asia-Pacific is estimated to register a significant growth due to the increasing pharmaceutical production, a sizeable patient pool, rising consumer awareness, and the need for novel packaging materials.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Pharmaceutical Blister Packaging Market Share Analysis
The pharmaceutical blister packaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pharmaceutical blister packaging market.
Some of the major players operating in the pharmaceutical blister packaging market are Schott (Germany), Amcor plc (Switzerland), Dow (U.S), AptarGroup, Inc., (US), Klöckner Pentaplast (Germany), West Pharmaceutical Services, Inc. (US), Berry Global Inc. (US), Honeywell International, Inc. (U.S), ACG (India), Nipro (Japan), Gerresheimer AG (Germany), Catalent Inc., (US), and WestRock Company (US) among others.
SKU-